EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Resection Margins and Adjuvant Therapy on Survival Outcomes in Lymph Node-Negative Distal Cholangiocarcinoma

Hye Jin Kang, In Young Jo iD

Current Oncology · 2025

DOI: 10.3390/curroncol32030178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2025. Verfasst von Hye Jin Kang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Margins of Excision. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Soonchunhyang University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prognostic value of the resection margin (RM) status and the efficacy of adjuvant therapy (AT) in distal cholangiocarcinoma (CCC) are unclear. RM status appears particularly impactful in lymph node-negative distal CCC, representing early-stage disease. The prognostic value of RM status was investigated, and subpopulations of patients with lymph node-negative distal CCC who might benefit from AT were identified. Overall, 139 patients with distal CCC who underwent surgical resection between March 2006 and December 2023 were analyzed. RM status was categorized as wide (>5 mm) in 65 patients (46.8%), close (≤5 mm) in 32 patients (23.0%), or positive in 42 patients (30.2%). AT was administered to 48 patients (34.5%). Patients with close or positive RMs achieved significantly lower locoregional control (LRC) than those with wide RMs. However, overall survival (OS) did not differ across the three RM groups. The impact of RM status was more evident in patients not receiving AT. Patients with wide RMs exhibited better 3-year LRC, progression-free survival (PFS), and OS rates (79.0%, 66.5%, and 69.1%, respectively) than those with close (21.7%, 15.7%, and 34.4%) or positive RMs (44.3%, 25.3%, and 50.2%, respectively). No significant differences were found between close and positive RM groups. AT appears to have improved LRC and PFS in patients with close or positive RMs but not in those with wide RMs. Close RMs were associated with poor outcomes comparable to those with positive RMs. These results indicate that achieving adequate RM width is crucial for improving survival. Moreover, AT may improve survival when adequate RMs cannot be achieved. Nonetheless, larger studies are needed to validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBile Duct NeoplasmsMargins of ExcisionHumansMaleFemaleMiddle AgedAgedChemotherapy, AdjuvantAdultPrognosisRetrospective StudiesTreatment OutcomeLymph Nodes

Stichwörter der Autor:innen

adjuvant therapydistal cholangiocarcinomaprognostic factorresection margintreatment outcome

Autor:innen und Institutionen

  • Department of Radiation Oncology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Department of Radiation Oncology, College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea.

ORCID-Profile: In Young Jo

Förderung

  • Soonchunhyang University

Zitieren

APA

Kang, H. J., & Jo, I. Y. (2025). Impact of Resection Margins and Adjuvant Therapy on Survival Outcomes in Lymph Node-Negative Distal Cholangiocarcinoma. Current Oncology. https://doi.org/10.3390/curroncol32030178

Vancouver

Kang HJ, Jo IY. Impact of Resection Margins and Adjuvant Therapy on Survival Outcomes in Lymph Node-Negative Distal Cholangiocarcinoma. Current Oncology. 2025. doi:10.3390/curroncol32030178

BibTeX
@article{Kang2025,
  author = {Kang, Hye Jin and Jo, In Young},
  title = {Impact of Resection Margins and Adjuvant Therapy on Survival Outcomes in Lymph Node-Negative Distal Cholangiocarcinoma},
  journal = {Current Oncology},
  year = {2025},
  doi = {10.3390/curroncol32030178}
}
Kostenlos starten →